ENTITY
Shenyang Xingqi Pharmaceutical

Shenyang Xingqi Pharmaceutical (300573 CH)

36
Analysis
Health Care • China
Shenyang Xingqi Pharmaceutical Co., Ltd. is a pharmaceutical company. The Company researches, produces, and distributes ophthalmic medicines including anti-bacterial products, allergy medicines, cataract preventions, and glaucoma treatments.
more
bullish•Ruijie Networks
•16 Jan 2025 15:02

Quiddity Leaderboard ChiNext & ChiNext 50 Jun 25: Great Momentum for the Exp ADDs Vs Exp DELs Trade

The expected ADDs have been sharply outperforming the expected DELs and that could continue over the next few weeks/months.

Share
•02 Dec 2024 15:42

Quiddity ChiNext/ChiNext 50 Dec 24 Results: ~80% Hit Rate; US$1bn+ One-Way Flows

We estimate US$851mn and US$191mn one-way flows for the ChiNext and ChiNext 50 December 2024 index rebal events respectively.

Share
•02 Dec 2024 10:57

ChiNext/​​ChiNext 50 Index Rebalance: US$1.7bn Round-Trip Trade

There are 7 changes for the Chinext and 5 changes for the Chinext50. The round-trip trade across both indices is estimated to be CNY 12.24bn...

Logo
479 Views
Share
•05 Nov 2024 16:45

Quiddity Leaderboard ChiNext Dec 24: Several Last-Minute Surprises; New Trade Idea

We estimate one-way flows of US$578mn for the ChiNext index rebalance and US$171mn for the ChiNext 50 rebalance in December 2024.

Share
•31 Oct 2024 05:30

ChiNext/​​​ChiNext50 Index Rebalance Preview: Jiangsu Hoperun's Multiple Index Inclusions & Big Risk

Review period ends today. We see 8 Chinext, 5 Chinext50 changes. Jiangsu Hoperun will have US$430m to buy, plus flows from CSI trackers, plus...

Logo
531 Views
Share
x